A major advance in cancer investigation is emerging with the use of mini-antibodies to reactivate damaged p53. This vital malignant inhibitor protein is frequently inactivated in several forms of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research